rabies vaccine for rabies

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jul 2022: Trial registered, NCT05453487
  2. 21 Jul 2022: Trial started, NCT05453487

The trials

NCT05453487: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

State
State not given
Phase
Phase 4
People
360 planned
Started
21 Jul 2022
Primary completion
30 Oct 2022
Arms
Rabies vaccine group
Results
None posted
  1. 12 Jul 2022: Trial registered
  2. 21 Jul 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.